Cardicomm Solutions, Inc. Press Releases

--> TORONTO, ONTARIO - CardioComm Solutions, Inc. ("CardioComm" or the "Company") (TSX VENTURE:EKG) a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, issued 62,500 stock options to Etienne Grima, the Company's CEO, in accordance with his employment agreement. The options are exercisable at $0.05 per share for five years from the date of grant and vest immediately. The grants are subject to the...

TORONTO, ONTARIO - CardioComm Solutions, Inc. ("CardioComm" or the "Company") (TSX VENTURE:EKG) a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, confirms it has filed an application with the USA Food and Drug Administration ("FDA") for premarket notification 510(k), Class II medical device clearance of the Company's newest HeartCheck™ branded, handheld heart rhythm monitor. The CardioComm...

TORONTO, ONTARIO - CardioComm Solutions, Inc. ("CardioComm" or the "Company") (TSX VENTURE:EKG) a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, has initiated the application process to the USA Food and Drug Administration ("FDA") for premarket notification 510(K), Class II medical device clearance of the Company's newest consumer-based and HeartCheck™ branded, hand-held heart rhythm...

TORONTO, ONTARIO - CardioComm Solutions, Inc. ("CardioComm" or the "Company") (TSX VENTURE:EKG) today announced that its board of directors has adopted an advance notice policy (the “Advance Notice Policy”). The purpose of the Advance Notice Policy is to provide shareholders, directors and management of the Company with direction on the procedure for shareholder nomination of directors. The Advance Notice Policy is the framework by which the Company seeks to fix a...

TORONTO, ONTARIO - CardioComm Solutions, Inc. ("CardioComm" or the "Company") (TSX VENTURE:EKG) is pleased to announce that it held business meetings with 25 technology companies during an Ontario Trade Delegation visit to Japan and Korea from February 20 to 27. The meetings were arranged through the assistance of the Ontario Ministry of International Trade with Global Affairs Canada representatives in Japan and Korea, the Osaka Prefecture Government, Economic Affairs Government...

TORONTO, ONTARIO - CardioComm Solutions, Inc. ("CardioComm" or the "Company") (TSX VENTURE:EKG) is participating in a series of meetings organized by the Ontario Trade Commission in partnership with Global Affairs Canada which has led to a delegation visit to Japan and Korea from February 20th to 27th. Through the assistance of the Trade Commission, meetings were held in November 2017 with visiting Japanese hospital representatives in Toronto in advance of CardioComm's visit to...

TORONTO, ONTARIO – Global medical electrocardiogram ("ECG") software and device manufacturer CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company"), today confirmed that it has officially released GEMS™ Home Flex for HeartCheck™ ECG devices that work on either a Mac or Windows operating system. Availability of the newly released GEMS™ Home Flex will support expanded use of both the HeartCheck™ ECG PEN and the...

TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, today announced the appointment of Bank of Montreal veteran Mr. Steven Benyo, CPA, CA as the newest member of the Company's Board of Directors ("BOD") and as a member of the Company's Audit and Finance Committee. Mr. Benyo is a highly experienced risk management...

This Press release is available by request only.Please Contact Us if you would like to receive a copy.

TORONTO, ONTARIO – Established medical electrocardiogram ("ECG") software and device manufacturer CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm" or the "Company") today confirmed it has been recognized as one of the 10 Most Promising Patient Monitoring Solution Providers for 2017 by California-based technology magazine CIOReview. The special edition award recognizes CardioComm's ability to influence patient monitoring technologies by tackling roadblocks for the...

TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, today announced the appointment of Dr. John Foote, MD, CCFP(EM) from Mount Sinai Hospital, Toronto, Ontario, as the newest member of the Company’s Board of Directors ("BOD") and the resignation of BOD member Mr. William Smith. The Company confirms it expects to...

Palm Desert, CA, Oct. 12, 2017 (GLOBE NEWSWIRE) -- Cytta Corp. (OTCPINK:CYCA), a leading provider of mobile smartphone and web based healthcare technology solutions, and CardioComm Solutions, Inc. ("CardioComm") (TSX VENTURE:EKG), a Canada based global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software and hardware solutions, today announced completion of a Joint Venture Agreement ("Agreement"). Under the announced Agreement both parties...

TORONTO, ONTARIO - a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") management software solutions, today announced that it has completed a custom software engineering contract with UK based Remote Diagnostic Technologies Limited ("RDT") for development and licensing of a remote, cloud-based, 12 lead ECG management and ECG reading solution. RDT specializes in the design of highly integrated mobile, vital signs, tele-monitoring solutions...

TORONTO, ONTARIO - Established medical electrocardiogram ("ECG") software and device manufacturer CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company"), today announced it has received the ACQ5 award as the Niche Technology Company of the Year in the Healthcare and Telemedicine category. The ACQ5 2017 award is sponsored by Acquisition Finance which is published under license from the Metropolis International Group Ltd. The magazine is circulated...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”)a leading global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, released its second quarter 2017 financials demonstrating continued sales growth, a profitable 2017 year to date, and a net profitable position over the past four fiscal quarters. The Q2 numbers are the result of...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”)a leading global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, today announced it has integrated its ECG viewer and Smart Monitoring ECG service with telemedicine provided by France based Visiomed Group SA ("Visiomed"). Under the annual, renewable software license agreement (the...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a leading global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, today announced it has been awarded a $567,079 grant from the Canada-Israel Industrial Research and Development Foundation ("CIIRDF") to enable R&D collaborations with HealthWatch Technologies Ltd. ("HealthWatch") of...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a consistent, global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, released its first quarter 2017 financials and confirms its strongest fiscal performance continues with a profitable start to 2017. The Company's management continues to maintain control over expenses while protecting...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a global medical provider of consumer heart monitoring and medical electrocardiogram software solutions, today announced that it has granted an aggregate of 1,000,000 stock options to the directors of the Company as remuneration for their contributions to the Company as members of the board and board committees. The options are exercisable...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a consistent, global medical provider of consumer heart monitoring and medical electrocardiogram (“ECG”) software solutions, today released its 2016 year end financials and confirms its strongest fiscal performance yet. The Company's management has worked to successfully reduce expenses while maintaining overall revenue...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a consistent, global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, today announced it has entered into a development, distribution and co-marketing agreement with Israel-based HealthWatch Technologies Ltd. ("HealthWatch") for the development, sales and marketing of a smart shirt based...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, today announced a partnership with CareSpan USA Inc., a leading provider of digital healthcare delivery systems, entered into on April 21, 2017. Under the agreement the parties have agreed to integrate CardioComm's cloud-based...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it has closed its previously announced equity financing for gross proceeds of $76,000. The equity financing was conducted to allow parties who were not able to participate in the Company’s December 2016 private placement to invest in the Company. The proceeds from the financing will be used for general operations,...

Financing allows investment by parties not able to participate in December, 2016 equity raise TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it is conducting a non-brokered private placement equity financing under which it intends to issue up to 3,000,000 units at a price of $0.05 per unit for gross proceeds of up to $150,000. Each unit will be comprised of one...

Private placement remains open while the Company readies efforts for new initiatives in 2017 TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it has closed its previously announced debt financing of $600,000 and the first tranche of its previously announced equity financing for gross proceeds of $500,000. Under the terms of the debt financing, the Company has borrowed...

$1.169M in debt and equity fundraising and debt reduction is the foundation for continued growth in 2017 TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that the Company is: Conducting a non-brokered debt financing under which it intends to raise up to $600,000; Intending to close the first $500,000 tranche of its $650,000 private placement initiative announced December...